[HTML][HTML] A prospective randomised trial to study the role of levamisole and interferon alfa in an adjuvant therapy with 5-FU for stage III colon cancer

W Schippinger, M Jagoditsch, C Sorre, M Gnant… - British journal of …, 2005 - nature.com
The purpose of this trial was to examine the efficacy of the addition of levamisole (LEV) or
interferon alfa (IFN) to an adjuvant chemotherapy with 5-fluorouracil (5-FU) in patients with …

[引用][C] A prospective randomised trial to study the role of levamisole and interferon alfa in an adjuvant therapy with 5-FU for stage III colon cancer

W SCHIPPINGER, M JAGODITSCH… - British journal of …, 2005 - pascal-francis.inist.fr
A prospective randomised trial to study the role of levamisole and interferon alfa in an
adjuvant therapy with 5-FU for stage III colon cancer CNRS Inist Pascal-Francis CNRS …

[HTML][HTML] A prospective randomised trial to study the role of levamisole and interferon alfa in an adjuvant therapy with 5-FU for stage III colon cancer

W Schippinger, M Jagoditsch, C Sorré… - British Journal of …, 2005 - ncbi.nlm.nih.gov
The purpose of this trial was to examine the efficacy of the addition of levamisole (LEV) or
interferon alfa (IFN) to an adjuvant chemotherapy with 5-fluorouracil (5-FU) in patients with …

[PDF][PDF] A prospective randomised trial to study the role of levamisole and interferon alfa in an adjuvant therapy with 5-FU for stage III colon cancer

W Schippinger, M Jagoditsch, C Sorré, M Gnant… - British Journal of …, 2005 - Citeseer
MATERIALS AND METHODS This multicentre trial was initiated by the Austrian Breast and
Colorectal Cancer Study Group (ABCSG) and involved 41 participating hospitals. The …

[引用][C] A prospective randomised trial to study the role of levamisole and interferon alfa in an adjuvant therapy with 5-FU for stage III colon cancer.

W Schippinger, M Jagoditsch, C Sorré… - BRITISH JOURNAL …, 2005 - pure.pmu.ac.at
A prospective randomised trial to study the role of levamisole and interferon alfa in an
adjuvant therapy with 5-FU for stage III colon cancer. — PMU Forschungsportal Zur …

A prospective randomised trial to study the role of levamisole and interferon alfa in an adjuvant therapy with 5-FU for stage III colon cancer

W Schippinger, M Jagoditsch, C Sorré… - British journal of …, 2005 - pubmed.ncbi.nlm.nih.gov
The purpose of this trial was to examine the efficacy of the addition of levamisole (LEV) or
interferon alfa (IFN) to an adjuvant chemotherapy with 5-fluorouracil (5-FU) in patients with …

[PDF][PDF] A prospective randomised trial to study the role of levamisole and interferon alfa in an adjuvant therapy with 5-FU for stage III colon cancer

W Schippinger, M Jagoditsch, C Sorré, M Gnant… - British Journal of …, 2005 - abcsg.org
MATERIALS AND METHODS This multicentre trial was initiated by the Austrian Breast and
Colorectal Cancer Study Group (ABCSG) and involved 41 participating hospitals. The …

A prospective randomised trial to study the role of levamisole and interferon alfa in an adjuvant therapy with 5-FU for stage III colon cancer.

W Schippinger, M Jagoditsch, C Sorré… - British Journal of …, 2005 - search.ebscohost.com
The purpose of this trial was to examine the efficacy of the addition of levamisole (LEV) or
interferon alfa (IFN) to an adjuvant chemotherapy with 5-fluorouracil (5-FU) in patients with …

[PDF][PDF] A prospective randomised trial to study the role of levamisole and interferon alfa in an adjuvant therapy with 5-FU for stage III colon cancer

W Schippinger, M Jagoditsch, C Sorré… - British Journal of …, 2005 - researchgate.net
MATERIALS AND METHODS This multicentre trial was initiated by the Austrian Breast and
Colorectal Cancer Study Group (ABCSG) and involved 41 participating hospitals. The …

[PDF][PDF] A prospective randomised trial to study the role of levamisole and interferon alfa in an adjuvant therapy with 5-FU for stage III colon cancer

W Schippinger, M Jagoditsch, C Sorré… - British Journal of …, 2005 - academia.edu
MATERIALS AND METHODS This multicentre trial was initiated by the Austrian Breast and
Colorectal Cancer Study Group (ABCSG) and involved 41 participating hospitals. The …